Efficacy and safety of conbercept as a primary treatment for choroidal neovascularization secondary to punctate inner choroidopathy

BACKGROUND: To evaluate the efficacy and safety of intravitreal conbercept (KH902) as the primary treatment of choroidal neovascularization secondary to punctate inner choroidopathy. METHODS: This study was a retrospective, consecutive, observational case series. We reviewed medical records of 16 ey...

Descripción completa

Detalles Bibliográficos
Autores principales: Peng, Yuting, Zhang, Xiongze, Mi, Lan, Liu, Bing, Zuo, Chengguo, Li, Miaoling, Wen, Feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5468989/
https://www.ncbi.nlm.nih.gov/pubmed/28606070
http://dx.doi.org/10.1186/s12886-017-0481-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5468989/
https://www.ncbi.nlm.nih.gov/pubmed/28606070
http://dx.doi.org/10.1186/s12886-017-0481-8

Ejemplares similares